In honor of March Madness, The Motley Fool's health-care team assembled their own bracket consisting of the 16 largest and best pharmaceutical and biotech stocks on the market. The series gets under way with a tough matchup between AbbVie (ABBV 0.29%), Abbott's recently spun-off pharmaceutical division, and Big Pharma giant GlaxoSmithKline (GSK 0.41%). To learn the bull and bear cases for each stock -- and to see which stock will move on to the Elite Eight -- watch the following video.
You might be more interested in March Madness, but if you're a long-term investor, the first round of Market Madness will keep you on the edge of your seat.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo